Delivery Order SPE2DB20D3104-SPE2DB23FV3L6
Award Date 10/26/22
Potential Completion Date 10/27/22
Potential Value $2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension medication to the Defense Logistics Agency (DLA). The $1,431.62 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the supply of Quillivant XR 25 mg/5 ml suspension (120 ml) to the Defense Logistics Agency (DLA). The $2,860.23 firm-fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, which runs through November 2026, enables the efficient procurement of a...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension (60 ml) to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The single-award, firm-fixed-price delivery order, valued at $1,524.36, was issued to the Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a wide range of...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension, valued at $1,477.70, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range...
- This federal contract award is for the pharmaceutical product Quillivant XR 25 mg/5 ml suspension, 120 ml, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,619.38 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with a completion date of December 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 180 ml bottles to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on August 11, 2021, with a ceiling value of $2,910.20. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the U.S. The $2,413.57 Firm Fixed Price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension (60 ml). This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,419.60, was awarded to prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a firm fixed-price delivery order contract with an ultimate completion date of October 28, 2024. The contract does not have a set-aside designation, indicating open...
- This federal contract award is for the pharmaceutical product Quillivant XR 25 mg/5 ml suspension, 180 ml, awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA). The $3,058.49 firm fixed-price delivery order has a completion date of November 20, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,524.36 firm fixed price delivery order covers the supply of Quillivant XR 25 mg/5 ml suspension, a specialty medication. This award is associated with Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...